Literature DB >> 28482642

Extracellular Tau Oligomers Induce Invasion of Endogenous Tau into the Somatodendritic Compartment and Axonal Transport Dysfunction.

Eric Swanson1, Leigham Breckenridge1, Lloyd McMahon2, Sreemoyee Som3, Ian McConnell1, George S Bloom1,2,4.   

Abstract

Aggregates composed of the microtubule associated protein, tau, are a hallmark of Alzheimer's disease and non-Alzheimer's tauopathies. Extracellular tau can induce the accumulation and aggregation of intracellular tau, and tau pathology can be transmitted along neural networks over time. There are six splice variants of central nervous system tau, and various oligomeric and fibrillar forms are associated with neurodegeneration in vivo. The particular extracellular forms of tau capable of transferring tau pathology from neuron to neuron remain ill defined, however, as do the consequences of intracellular tau aggregation on neuronal physiology. The present study was undertaken to compare the effects of extracellular tau monomers, oligomers, and filaments comprising various tau isoforms on the behavior of cultured neurons. We found that 2N4R or 2N3R tau oligomers provoked aggregation of endogenous intracellular tau much more effectively than monomers or fibrils, or of oligomers made from other tau isoforms, and that a mixture of all six isoforms most potently provoked intracellular tau accumulation. These effects were associated with invasion of tau into the somatodendritic compartment. Finally, we observed that 2N4R oligomers perturbed fast axonal transport of membranous organelles along microtubules. Intracellular tau accumulation was often accompanied by increases in the run length, run time and instantaneous velocity of membranous cargo. This work indicates that extracellular tau oligomers can disrupt normal neuronal homeostasis by triggering axonal tau accumulation and loss of the polarized distribution of tau, and by impairing fast axonal transport.

Entities:  

Keywords:  Alzheimer’s disease; BACE1; axonal transport; brain derived neurotrophic factor; neuropeptide Y; tau; tauopathies

Mesh:

Substances:

Year:  2017        PMID: 28482642      PMCID: PMC5581403          DOI: 10.3233/JAD-170168

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  58 in total

1.  Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease.

Authors:  Kristina R Patterson; Christine Remmers; Yifan Fu; Sarah Brooker; Nicholas M Kanaan; Laurel Vana; Sarah Ward; Juan F Reyes; Keith Philibert; Marc J Glucksman; Lester I Binder
Journal:  J Biol Chem       Date:  2011-05-06       Impact factor: 5.157

2.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

Authors:  Jean C Augustinack; Anja Schneider; Eva-Maria Mandelkow; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

Review 3.  Lost after translation: missorting of Tau protein and consequences for Alzheimer disease.

Authors:  Hans Zempel; Eckhard Mandelkow
Journal:  Trends Neurosci       Date:  2014-09-12       Impact factor: 13.837

4.  Small misfolded Tau species are internalized via bulk endocytosis and anterogradely and retrogradely transported in neurons.

Authors:  Jessica W Wu; Mathieu Herman; Li Liu; Sabrina Simoes; Christopher M Acker; Helen Figueroa; Joshua I Steinberg; Martin Margittai; Rakez Kayed; Chiara Zurzolo; Gilbert Di Paolo; Karen E Duff
Journal:  J Biol Chem       Date:  2012-11-27       Impact factor: 5.157

5.  Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles.

Authors:  B Trinczek; A Ebneth; E M Mandelkow; E Mandelkow
Journal:  J Cell Sci       Date:  1999-07       Impact factor: 5.285

6.  Distinct tau prion strains propagate in cells and mice and define different tauopathies.

Authors:  David W Sanders; Sarah K Kaufman; Sarah L DeVos; Apurwa M Sharma; Hilda Mirbaha; Aimin Li; Scarlett J Barker; Alex C Foley; Julian R Thorpe; Louise C Serpell; Timothy M Miller; Lea T Grinberg; William W Seeley; Marc I Diamond
Journal:  Neuron       Date:  2014-05-22       Impact factor: 17.173

7.  Trans-synaptic spread of tau pathology in vivo.

Authors:  Li Liu; Valerie Drouet; Jessica W Wu; Menno P Witter; Scott A Small; Catherine Clelland; Karen Duff
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

8.  Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.

Authors:  Justin M Nussbaum; Stephan Schilling; Holger Cynis; Antonia Silva; Eric Swanson; Tanaporn Wangsanut; Kaycie Tayler; Brian Wiltgen; Asa Hatami; Raik Rönicke; Klaus Reymann; Birgit Hutter-Paier; Anca Alexandru; Wolfgang Jagla; Sigrid Graubner; Charles G Glabe; Hans-Ulrich Demuth; George S Bloom
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

Review 9.  The MAP2/Tau family of microtubule-associated proteins.

Authors:  Leif Dehmelt; Shelley Halpain
Journal:  Genome Biol       Date:  2004-12-23       Impact factor: 13.583

10.  Internalized Tau Oligomers Cause Neurodegeneration by Inducing Accumulation of Pathogenic Tau in Human Neurons Derived from Induced Pluripotent Stem Cells.

Authors:  Marija Usenovic; Shahriar Niroomand; Robert E Drolet; Lihang Yao; Renee C Gaspar; Nathan G Hatcher; Joel Schachter; John J Renger; Sophie Parmentier-Batteur
Journal:  J Neurosci       Date:  2015-10-21       Impact factor: 6.167

View more
  22 in total

Review 1.  Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.

Authors:  Nalini Vijay Gorantla; Subashchandrabose Chinnathambi
Journal:  J Mol Neurosci       Date:  2018-09-28       Impact factor: 3.444

Review 2.  Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease.

Authors:  Tara E Tracy; Li Gan
Journal:  Curr Opin Neurobiol       Date:  2018-05-10       Impact factor: 6.627

3.  Distinct Neurotoxic Effects of Extracellular Tau Species in Primary Neuronal-Glial Cultures.

Authors:  Katryna Pampuscenko; Ramune Morkuniene; Lukas Krasauskas; Vytautas Smirnovas; Taisuke Tomita; Vilmante Borutaite
Journal:  Mol Neurobiol       Date:  2020-10-01       Impact factor: 5.590

4.  Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism.

Authors:  Joanna M Cooper; Aurelien Lathuiliere; Mary Migliorini; Allison L Arai; Mashhood M Wani; Simon Dujardin; Selen C Muratoglu; Bradley T Hyman; Dudley K Strickland
Journal:  J Biol Chem       Date:  2021-04-27       Impact factor: 5.157

5.  SOD1 mediates lysosome-to-mitochondria communication and its dysregulation by amyloid-β oligomers.

Authors:  Andrés Norambuena; Xuehan Sun; Horst Wallrabe; Ruofan Cao; Naidi Sun; Evelyn Pardo; Nutan Shivange; Dora Bigler Wang; Lisa A Post; Heather A Ferris; Song Hu; Ammasi Periasamy; George S Bloom
Journal:  Neurobiol Dis       Date:  2022-04-20       Impact factor: 7.046

Review 6.  Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration.

Authors:  Nicole Cortés; Víctor Andrade; Leonardo Guzmán-Martínez; Matías Estrella; Ricardo B Maccioni
Journal:  Int J Mol Sci       Date:  2018-03-23       Impact factor: 5.923

Review 7.  Axonal Degeneration in Tauopathies: Disease Relevance and Underlying Mechanisms.

Authors:  Andrew Kneynsberg; Benjamin Combs; Kyle Christensen; Gerardo Morfini; Nicholas M Kanaan
Journal:  Front Neurosci       Date:  2017-10-17       Impact factor: 4.677

8.  Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer's disease.

Authors:  Malcolm Roberts; Ioanna Sevastou; Yoichi Imaizumi; Kavita Mistry; Sonia Talma; Madhurima Dey; Jane Gartlon; Hiroshi Ochiai; Zhi Zhou; Shigeru Akasofu; Naoki Tokuhara; Makoto Ogo; Muneo Aoyama; Hirofumi Aoyagi; Kate Strand; Ezat Sajedi; Kishan Lal Agarwala; Jared Spidel; Earl Albone; Kanta Horie; James M Staddon; Rohan de Silva
Journal:  Acta Neuropathol Commun       Date:  2020-02-04       Impact factor: 7.801

Review 9.  Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer's Disease.

Authors:  Xiaomin Yin; Chenhao Zhao; Yanyan Qiu; Zheng Zhou; Junze Bao; Wei Qian
Journal:  Front Mol Neurosci       Date:  2021-06-25       Impact factor: 5.639

10.  TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD.

Authors:  Matthew A White; Eosu Kim; Amanda Duffy; Robert Adalbert; Benjamin U Phillips; Owen M Peters; Jodie Stephenson; Sujeong Yang; Francesca Massenzio; Ziqiang Lin; Simon Andrews; Anne Segonds-Pichon; Jake Metterville; Lisa M Saksida; Richard Mead; Richard R Ribchester; Youssef Barhomi; Thomas Serre; Michael P Coleman; Justin R Fallon; Timothy J Bussey; Robert H Brown; Jemeen Sreedharan
Journal:  Nat Neurosci       Date:  2018-03-19       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.